Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Geriatric Assessment × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Head & Neck 1 Gynecologic 1 Genitourinary 1

Conditions

Ovarian Neoplasms 5 Fallopian Tube Neoplasms 2 Postoperative Complications 1 Neoplasms 1 Frailty 1 Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 23 Carboplatin 23 pembrolizumab 22 liposomal doxorubicin 11 Cisplatin 10 Bevacizumab 10 Gemcitabine 8 Cyclophosphamide 8 Blood Specimen Collection 8 Topotecan 7 Radiotherapy 7 olaparib 6 Nivolumab 6 Drug Therapy 6 Therapeutics 5 Doxorubicin 5 Dexamethasone 5 pertuzumab 4 pazopanib 4 lenvatinib 4 fludarabine 4 Trastuzumab 4 Surveys and Questionnaires 4 Docetaxel 4 Capecitabine 4 Brachytherapy 4 palbociclib 3 mirvetuximab soravtansine 3 budigalimab 3 atezolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06572735 2026-02-23

PARIB-OLD-PRO²

Hospices Civils de Lyon

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡